For instance, via thoroughly analyzing the epigenetic modification patterns of 1518 GC patients, a subtype with high FTO level was identified to correlate with poor survival and immunotherapy resistance, which are potentially benefited from combination FTO inhibition and ICB [155]. The gene discussed is FTO; the disease is gastric cancer.